THE HISTOLOGIC PHENOTYPES OF BREAST-CARCINOMA OCCURRING BEFORE AGE 40YEARS IN WOMEN WITH AND WITHOUT BRCA1 OR BRCA2 GERMLINE MUTATIONS - APOPULATION-BASED STUDY
Je. Armes et al., THE HISTOLOGIC PHENOTYPES OF BREAST-CARCINOMA OCCURRING BEFORE AGE 40YEARS IN WOMEN WITH AND WITHOUT BRCA1 OR BRCA2 GERMLINE MUTATIONS - APOPULATION-BASED STUDY, Cancer, 83(11), 1998, pp. 2335-2345
BACKGROUND. Women with breast carcinoma diagnosed before age 40 years
have a greater prevalence of germline BRCA1 and BRCA2 mutations than w
omen with breast carcinoma diagnosed at older ages. Several recognizab
le histologic characteristics have been identified in breast carcinoma
from studies of BRCA1/2 mutation carriers who belong to multiple-case
families. The authors attempted to determine whether breast carcinoma
occurring before age 40 years in BRCA1 or BRCA2 mutation carriers who
were not selected for family history could be distinguished histologi
cally from one another and from breast carcinoma in women of a similar
age without a germline BRCA1 or BRCA2 mutation. METHODS. The study un
dertook a histologic assessment of breast carcinomas diagnosed before
age 40 years identified from a population-based study. RESULTS. Breast
carcinoma in BRCA1 mutation carriers was associated with a distinct h
istologic appearance; these tumors were high grade, and had exceptiona
lly high mean mitotic counts, a syncytial growth pattern, pushing marg
ins, and confluent necrosis. Atypical medullary carcinoma was overrepr
esented in BRCA1 mutation carriers. All low grade tumors and tumors wi
th low mitotic rates belonged to the group without BRCA1 or BRCA2 muta
tions. Pleomorphic lobular carcinomas and extensive intraduct carcinom
as were more common in BRCA2 mutation carriers. CONCLUSIONS. Breast ca
rcinoma occurring in women with a germline BRCA1 or BRCA2 mutation hav
e recognizable histologic phenotypes, which may be useful in identifyi
ng individuals more likely to carry germline mutations. Histologic exa
mination of breast carcinoma should become an important part of the ev
aluation of women seeking genetic testing for germline mutations in th
ese breast carcinoma susceptibility genes. (C) 1998 American Cancer So
ciety.